:101.9.12:

1 5 0 6( M o r e y e t a l . , 2 0 0 8 )

(p . 0 0 1 ) S u a y a , S h e p a r d , &S t a s o n ( 2 0 1 0 )

N1573()9 7 . 8 % 83.7%70()94.7%75.4%

1.: (nitric oxide)Hambrecht R, Fiehn E, Yu J, et al. 1997

2. Hambrecht R, Fiehn E, Yu J, et al. 1997

3.:B(B-type natriureticpeptide, BNP)(vasopressin) (aldosterone)(artrial natriureticpeptide) 6Braith RW, Welsch MA, Feigenbaum MS, Kluess HA,Pepine CJ. 1999

4.(interleukin-6)(tumor necrosis factor)8Gielen S, Adams V, Mobius-Winkler S, et al. 2003

Phase 1: coronary care unit (CCU)~(onset 3~6 day)Phase 2:2~3Phase 3: (maximal exercise test),Phase 4:

1.:()

2.:,

3.:1.:,,,2.:3.4.:,

4.(Love-level exercise test):,,:,5MET120~130.,,,(ST>_2mm,),

::

1.:/-/(immobility)After 2 weeks:After 2 weeks:

-(MMT>3)

2.: Aerobic exercise :ATP ATPATP (American College of Sports of Medicine) 15

:

3.: ... ,, . ,,, ,(), ,, ,.

1.

>100bpm or 160/90 mmHg or 10/minPVCPVC

2.

BP>220/120 mmHg BPAbnormal EKG: ,,,,,,,,,,

ACSM:

1.RPE scale : 132. 120 or +20

Gunnar Borg1970198519941998

6 no exertion at all 7 extremely light 8 9 very light 10 11 light 12 13 somewhat hard 14 15 hard/heavy 16 17 very hard 18 19 extremely hard 20 maximal exertion

MET 1.0 1.,, 2.10 3.1~2 10 20 2~55~10(10)2~5 2~3.5 (2.5METs)2~5 mints/2sessions/day3.5METs 7~11mints/2sessions/day 12Free ambulation

~

MET 1.0 1.455 2.10 3.10 1. 2. - 1.5 1.5 2.10 3.15-30 4.40 1. 2. 3. 4. 2.0 1.5 2.10 3.12 4.60 1. 2. 3. 4. 2.5 1.10 2.10 3.10 4.1080() 1. 2. 3.0 1.10 2.10 3.100 1. 2. 3.5 1.10 2.110 3.110 4.120 1. 2.

Phase of cardiac rehabilitation: A new challenge for evidence based physiotherapy :World J Cardiol 2011 July 26; 3(7): 248-255 :2010 ACSMUnderutilization of Exercise-Based Cardiac Rehabilitation: Barriers to Referral, Participation and Delivery 2011nursingcrib.com

4**(catecholamine)

6(sympathetic nerve)(heart rate variability)(heart rate recovery)7*(cytokines)* ()

*B*AMI*-(MMT>3)* ,(Range Of Motion) , ,(Mobility)*(cytokines)*